Is Change in Albuminuria a Surrogate Marker for Cardiovascular and Renal Outcomes in Type 1 Diabetes?
Author(s) -
Bradley S. Dixon
Publication year - 2016
Publication title -
clinical journal of the american society of nephrology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.755
H-Index - 151
eISSN - 1555-905X
pISSN - 1555-9041
DOI - 10.2215/cjn.09540916
Subject(s) - microalbuminuria , medicine , albuminuria , diabetic nephropathy , type 1 diabetes , diabetes mellitus , endocrinology , type 2 diabetes mellitus , nephropathy , urology , type 2 diabetes
In 1963, Keen and Chlouverakis published a new immunoassay that detected urine albumin at low concentrations and subsequently showed that urine (micro)albumin was elevated in patients with diabetes after a glucose load ([1][1]). In the early 1980s, several small longitudinal observational studies
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom